Eligibility Pre-Screening

Phase 2 Randomised controlled trial of bone-marrow derived mesenchymal stromal cells (MSC) for new onset chronic lung allograft dysfunction (CLAD)

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 70%

1.Are you 18 years of age or older and have you had a bilateral (two-lung) transplant at least 6 months ago?

Press Y/N or 1/2